Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology – Nature
Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology Nature
Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology Nature
PostSig Wins WatersTechnology Award for Best AI/Machine Learning Data Initiative Newswire 🙂 Press Release Distribution
CrowdStrike Stock Is Crushing the S&P 500 in 2025. Is the Artificial Intelligence (AI) Juggernaut Still a Buy? MSN
crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumors Nature
Zak Stein — AI’s Unseen Risks: How Artificial Intelligence Could Harm Future Generations resilience.org
How Can Quantum Machine Learning Serve as a Tool to Strengthen Quantum Key Distribution? The Quantum Insider
Most Read: IBM AI Innovation Hub Launches in New York City; China Smartphone Company Plans Humanoid Robots in $10B AI Plan AI Business
CrowdStrike Stock Is Crushing the S&P 500 in 2025. Is the Artificial Intelligence (AI) Juggernaut Still a Buy? The Globe and Mail
A committor-based method to uniformly sample rare reactive events Nature
OpenAI finds more Chinese groups using ChatGPT for malicious purposes Reuters